GlassScriptPhysician profile
Jaime Gremillion
NPI 1710205679
$4,401.63
in general payments reported to CMS, 2019-2025
12 companies · $357 in 2025
The $357 reported for 2025 was more than what 95% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
See the full distribution for Nurse Anesthetist, Certified Registered
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $869 · 2022: $653 · 2023: $2,140 · 2024: $384 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,982 · Travel and Lodging: $898.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,981.83 |
| Travel and Lodging | $897.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $3,756.53 | 2021-2025 | Xeomin |
| Abbvie INC. | $195.06 | 2023 | |
| Glaxosmithkline, LLC. | $109.14 | 2022-2023 | Trelegy Ellipta |
| Medtronic, INC. | $93.47 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $55.72 | 2025 | Entyvio |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $54.31 | 2025 | Xifaxan |
| Madrigal Pharmaceuticals | $38.72 | 2025 | Rezdiffra |
| Janssen Biotech, INC. | $27.26 | 2025 | Tremfya |
| Inari Medical, INC. | $23.08 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pacira Pharmaceuticals Incorporated | $17.62 | 2025 | Exparel |
| Eagle Pharmaceuticals, INC. | $16.64 | 2022 | |
| Merck Sharp & Dohme LLC | $14.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaime Gremillion listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.